stoxline Quote Chart Rank Option Currency Glossary
  
Haemonetics Corporation (HAE)
69.7  -0.26 (-0.37%)    06-17 10:53
Open: 69.73
High: 70.1
Volume: 50,270
  
Pre. Close: 69.96
Low: 69.555
Market Cap: 3,348(M)
Technical analysis
2025-06-17 10:16:54 AM
Short term     
Mid term     
Targets 6-month :  86.16 1-year :  100.63
Resists First :  73.76 Second :  86.16
Pivot price 69.9
Supports First :  68.36 Second :  65.02
MAs MA(5) :  70.54 MA(20) :  69.23
MA(100) :  65.31 MA(250) :  74.35
MACD MACD :  1.2 Signal :  1.4
%K %D K(14,3) :  50.6 D(3) :  59.4
RSI RSI(14): 55.7
52-week High :  94.98 Low :  55.29
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ HAE ] has closed above bottom band by 48.0%. Bollinger Bands are 38.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 70.9 - 71.4 71.4 - 71.78
Low: 68.41 - 69.09 69.09 - 69.61
Close: 69.03 - 69.94 69.94 - 70.64
Company Description

Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Headline News

Tue, 10 Jun 2025
Market Participants Recognise Haemonetics Corporation's (NYSE:HAE) Earnings - simplywall.st

Sun, 01 Jun 2025
Are Investors Undervaluing Haemonetics Corporation (NYSE:HAE) By 36%? - Yahoo Finance

Fri, 30 May 2025
Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference - Quantisnow

Wed, 21 May 2025
HAEMONETICS CORP SEC 10-K Report - TradingView

Tue, 20 May 2025
JMP maintains Haemonetics stock $100 target post-results - Investing.com

Fri, 09 May 2025
Haemonetics Corp (HAE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 48 (M)
Shares Float 47 (M)
Held by Insiders 1 (%)
Held by Institutions 118.5 (%)
Shares Short 4,080 (K)
Shares Short P.Month 4,430 (K)
Stock Financials
EPS 3.3
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 17.02
Profit Margin 12.3 %
Operating Margin 17.2 %
Return on Assets (ttm) 6.6 %
Return on Equity (ttm) 18.8 %
Qtrly Rev. Growth -3.8 %
Gross Profit (p.s.) 16.2
Sales Per Share 28.3
EBITDA (p.s.) 7.41
Qtrly Earnings Growth 194.6 %
Operating Cash Flow 182 (M)
Levered Free Cash Flow 184 (M)
Stock Valuations
PE Ratio 21.08
PEG Ratio 0
Price to Book value 4.1
Price to Sales 2.46
Price to Cash Flow 18.45
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android